NCT01683006View on ClinicalTrials.gov

Influence of Skeletal Muscle Paralysis on Metabolism in Hypothermic Patients After Cardiac Arrest

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

November 30, 2014

Conditions
Critical IllnessCardiac Arrest
Interventions
DRUG

Rocuronium

"Continuous application of Rocuronium (0.5 mg/kg body weight/hour).~Bolus application of placebo in case of shivering."

DRUG

Placebo

"Continuous application of placebo during therapeutic hypothermia.~Bolus application of Rocuronium (0.5 mg/kg body weight) in case of shivering."

Trial Locations (1)

1090

Medical University Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01683006 - Influence of Skeletal Muscle Paralysis on Metabolism in Hypothermic Patients After Cardiac Arrest | Biotech Hunter | Biotech Hunter